trc105
Showing 1 - 13 of 13
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2022
Lung Cancer Trial in Birmingham (TRC105)
Completed
- Lung Cancer
- TRC105
-
Birmingham, AlabamaUAB Comprehensive Cancer Center
Jun 24, 2021
Solid Tumors Trial in Santa Monica (TRC105, Bevacizumab, Axitinib)
No longer available
- Solid Tumors
- TRC105
- +4 more
-
Santa Monica, CaliforniaUCLA
Jan 28, 2021
Prostate Cancer Trial in Los Angeles (TRC105, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer
- TRC105
- +2 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 4, 2020
Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor Trial in Boston, Columbus, Dallas
Terminated
- Gestational Trophoblastic Neoplasia
- +3 more
- TRC105
- Bevacizumab
-
Boston, Massachusetts
- +2 more
Jul 9, 2019
Glioblastoma, Glioblastoma Multiforme Trial in Cincinnati, Cleveland, Columbus (TRC105, Bevacizumab)
Completed
- Glioblastoma
- Glioblastoma Multiforme
- TRC105
- Bevacizumab
-
Cincinnati, Ohio
- +3 more
May 21, 2019
Metastatic Breast Cancer Trial in Birmingham, Buffalo (TRC105, Capecitabine)
Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer Trial run by the NCI (TRC105)
Completed
- Prostate Cancer
- Metastatic Castrate Resistant Prostate Cancer
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2018
Hepatocellular Carcinoma, Hepatocellular Cancer, Carcinoma, Hepatocellular Trial run by the NCI (TRC105)
Completed
- Hepatocellular Carcinoma
- +2 more
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2017
Urothelial Carcinoma, Ureteral Tumors, Ureter Cancer Trial run by the NCI (TRC105)
Completed
- Urothelial Carcinoma
- +4 more
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 16, 2016
Glioblastoma Multiforme Trial run by the NCI (TRC105)
Terminated
- Glioblastoma Multiforme
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 6, 2015